Outcome of newborn hearing screening by ABR compared with four different DPOAE pass criteria

American Journal of Audiology

Volumn 9, Issue 2, 2000, Pages 142-148

  Barker, S E ^a   Lesperance, M M ^a   Kileny, P R ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Auditory brain stem response; Newborn hearing screening; Otoacoustic emissions

Indexed keywords

ARTICLE; AUDITORY RESPONSE; BRAIN STEM RESPONSE; CONTROLLED STUDY; DISTORTION PRODUCT OTOACOUSTIC EMISSION; EVOKED BRAIN STEM RESPONSE; HEARING; HUMAN; HUMAN EXPERIMENT; INTERMETHOD COMPARISON; NEWBORN; NEWBORN SCREENING; NORMAL HUMAN; SCREENING TEST; STANDARDIZATION;

EID: 0034490017     PISSN: 10590889     EISSN: None     Source Type: Journal    
DOI: 10.1044/1059-0889(2000/017)     Document Type: Article

References (41)

1. Texas hospitals quality control approach to universal infant hearing detection
2. Newborn and infant hearing loss: Detection and intervention
3. Guidelines for screening for hearing impairment - Neonates and young infants, birth through 6 months
4. Distortion product otoacoustic emission and auditory brain stem response measures of pediatric sensorineural hearing loss with islands of normal sensitivity
5. Newborn hearing screening by otoacoustic emissions and automated auditory brainstem response
6. Comparison of newborn hearing screening by transient otoacoustic emissions and auditory brainstem response using ALGO-2
7. Otoacoustic emission versus ABR screening: The effect of external and middle ear abnormalities in a group of SCBU neonates
8. The auditory brain stem response reliably predicts hearing loss in graduates of a tertiary intensive care nursery
9. The behavior of the acoustic distortion product, 2f1-f2, from the human ear and its relation to auditory sensitivity
10. Otoacoustic emissions
11. Otoacoustic emissions from normal-hearing and hearing-impaired subjects: Distortion product responses
12. From laboratory to clinic: A large scale study of distortion product otoacoustic emissions in ears with normal hearing and ears with hearing loss
13. Acoustic distortion products in humans: Systematic changes in amplitude as a function of f2/f1 ratio
14. The influence of systematic primary-tone level variation L2-L1 on the acoustic distortion product emission 2f1-f2 in normal human ears
15. Brain stem auditory evoked responses in human infants and adults
16. Automated infant hearing screening using the ABR: Development and validation
17. Feasibility of otoacoustic emission detection followed by ABR as a universal neonatal screening test for hearing impairment
18. 1994 position statement
19. Otoacoustic emissions and auditory brainstem responses in the newborn
20. New insights on infant ABR hearing screening
21. Clinical testing of distortion-product otoacoustic emissions
22. Distortion product otoacoustic emissions in healthy newborns: Normative data
23. Otoacoustic emissions in human ears: Normative findings
24. Universal infant hearing screening by automated auditory brainstem response measurement
25. Pass/fail rates for repeated click-evoked otoacoustic emission and auditory brain stem response screenings in newborns
26. Brain stem auditory evoked responses in children
27. Distortion product otoacoustic emissions: Hit and false-positive rates in normal-hearing and hearing-impaired subjects
28. Early identification of hearing impairment in infants and young children
29. Clinical significance of probe-tone frequency ratio on distortion product otoacoustic emissions
30. Comparison of distortion product otoacoustic emissions with auditory brain-stem response for clinical use in neonatal intensive care unit
31. Electrophysiologic changes in preterm neonates: Auditory brain stem response and distortion product otoacoustic emissions
32. Distortion-product otoacoustic emissions hearing screening in high risk newborns
33. Incidence of hearing loss in high risk and intensive care nursery infants
34. Brain stem evoked response audiometry in newborn hearing screening
35. Feasibility of acoustic distortion product testing in newborns
36. Development of auditory function in newborn infants revealed by auditory brainstem potentials
37. Toward optimizing the clinical utility of distortion product otoacoustic emission measurements
38. Distortion product otoacoustic emission test of sensorineural hearing loss in humans: Comparison of unequal- and equal-level stimuli
39. The Colorado newborn hearing screening project
40. ABR hearing screening for high-risk infants
41. The Rhode Island hearing assessment program: Experience with statewide screening (1993-1996)